Drug Shortages Shelf Life Extension Act
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Drug Shortages Shelf Life Extension Act
This bill requires the Food and Drug Administration (FDA) to issue or revise guidance to address issues relating to extending drug expiration dates.
Specifically, the guidance must address recommendations to drug companies relating to (1) submitting stability testing data in applications for market approval for drugs or biological products; (2) establishing on drug labels the longest feasible expiration date scientifically supported by such data, taking into consideration how extended expiration dates may help prevent or mitigate drug shortages and affect product quality; and (3) using innovative approaches to stability modeling to support initial product expiration dates and expiration date extensions.
The FDA must also periodically report to Congress certain information about requests to change the expiration date on a drug label, including the number of such requests from the FDA to the manufacturer and the rationale for each request.
Referred to the House Committee on Energy and Commerce.
- Introduced in House Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H.R. 7669: Drug Shortages Shelf Life Extension Act. 117th Congress. Open America. https://openamerica.io/bill/117-HR-7669/
"H.R. 7669: Drug Shortages Shelf Life Extension Act." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-HR-7669/.
H.R. 7669, 117th Cong. (2026), https://openamerica.io/bill/117-HR-7669/.
[H.R. 7669: Drug Shortages Shelf Life Extension Act](https://openamerica.io/bill/117-HR-7669/)